HealthQuill Haemophilia
Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder in haemophilia patients.
Drugs Health Pharma

Pfizer’s drug to treat rare haemophilia disorder gets US regulator’s approval

Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder.

Read More
Pfizer’s haemophilia A gene therapy has reduced bleeding rates in patients during an end-stage trial, according to a company statement.
Drugs Health Pharma

Pfizer’s haemophilia A gene therapy cuts bleeding rates during trials

HQ Team July 25, 2024: Pfizer’s haemophilia A gene therapy has reduced bleeding rates in patients during an end-stage trial, according to a.

Read More